上游生物加工市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

上游生物加工市场按产品(细胞培养产品、生物反应器/发酵罐、过滤器、生物反应器配件)、使用类型、模式和地理位置进行细分。

市场快照

Upstream Bioprocessing Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

上游生物加工市场预计在预测期内的复合年增长率为 5.5%。这归因于一次性上游生物工艺的日益普及、商业上的成功以及对生物治疗药物的需求不断增加以及市场供应商之间日益激烈的竞争。上游生物工艺在生物仿制药、治疗性肽和单克隆抗体的开发研究活动中非常重要。此外,上游生物工艺是无污染、安全、高效的生产,有助于这些工艺的需求进一步推动市场。此外,对过程分析技术 (PAT) 战略的认识和实施不断提高,以监控、通过实时营养分析和细胞密度在线监测等各种参数分析和优化细胞培养生产过程也有助于增加市场。该技术有助于上游生物工艺的关键质量属性,并进一步提高工艺的生产力并推动市场发展。然而,整体处理的高成本以及与该过程有关的操作挑战可能会阻碍市场。

报告范围

根据范围,上游生物加工处理使用活细胞来获得所需的产品。这个过程从早期的细胞分离、培养到细胞培养扩增到收获最终产品。上游生物加工市场按产品、使用类型、模式和地理划分。

By Product
Cell Culture Products
Bioreactors/Fermenters
Filters
Bioreactors Accessories
Others
By Usage Type
Single-Use
Multi-Use
By Mode
In-house
Outsourced
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

上游生物加工中的生物反应器/发酵罐有望在未来见证健康增长。

由于在小型和大型生物生产中的广泛应用,上游生物加工中的生物反应器/发酵罐预计将在未来出现健康增长。生物反应器的高使用率及其在安全性、成本效益方面的新发展也在推动市场。此外,细胞培养产品在市场上也显示出有利可图的机会,因为对高滴度生产细胞培养物的需求不断增加。

此外,随着全球研发支出的增加以及与上游加工相关的多项优势,推动了整体市场的发展。

img3 Upstream bioprocessing

北美预计将在市场上占有重要份额,预计在预测期内也将如此

由于研发支出的增加、主要市场参与者的存在、慢性病负担的增加以及完善的医疗保健基础设施,预计北美将在全球上游生物加工市场占据重要的市场份额。此外,对治疗淋巴瘤、类风湿性关节炎和糖尿病等多种疾病的蛋白质需求不断增加,其中特定蛋白质可以通过上游生物加工生产,进一步推动了该地区的市场。

Upstream geography.png

竞争格局

上游生物加工市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司包括 Thermo Fisher Scientific Inc.、GE Healthcare、Corning, Inc.、Merck KGaA、Eppendorf AG、Sartorius AG、Boehringer Ingelheim GmbH、Danaher Corporation、Applikon Biotechnology 和 CellGenix GmbH。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Adoption of Single-Use Upstream Bioprocessing

      2. 4.2.2 Commercial Success and Rising Demand for Biotherapeutics

    3. 4.3 Market Restraints

      1. 4.3.1 Operational Challenges Pertaining to Upstream Bioprocessing

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Cell Culture Products

      2. 5.1.2 Bioreactors/Fermenters

      3. 5.1.3 Filters

      4. 5.1.4 Bioreactors Accessories

      5. 5.1.5 Others

    2. 5.2 By Usage Type

      1. 5.2.1 Single-Use

      2. 5.2.2 Multi-Use

    3. 5.3 By Mode

      1. 5.3.1 In-house

      2. 5.3.2 Outsourced

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc.

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Corning, Inc.

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Eppendorf AG

      6. 6.1.6 Sartorius AG

      7. 6.1.7 Boehringer Ingelheim GmbH

      8. 6.1.8 Danaher Corporation

      9. 6.1.9 Applikon Biotechnology

      10. 6.1.10 CellGenix GmbH

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific Inc., GE Healthcare, Corning, Inc, Merck KGaA, Sartorius AG are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!